Survival rates can be calculated by different methods for different purposes. The pancreatic cancer survival rates presented here are based on the relative survival rate. The relative survival rate measures the survival of cancer patients in comparison to the general population to estimate the effect of cancer. The overall five-year relative pancreatic cancer survival rate for 1995-2001 was 4.6 percent. The five-year relative pancreatic cancer survival rates by race and sex were:
7 percent of pancreas cancer cases are diagnosed while the cancer is still confined to the primary site (localized stage).
26 percent of pancreas cancer cases are diagnosed after the cancer has spread to regional lymph nodes or directly beyond the primary site.
52 percent of pancreas cancer cases are diagnosed after the cancer has already metastasized (distant stage).
14 percent of pancreas cancer cases had staging information that was unknown.
The corresponding five-year relative survival rates were:
16.4 percent for localized
7.0 percent for regional
1.8 percent for distant
4.3 percent for unstaged.
Pancreatic Cancer Statistics: Lifetime Risk
Based on rates from 2000-2002, 1.27 percent of men and women (or 1 in 79 men and women) born today will be diagnosed with pancreatic cancer at some time during their lifetime. These statistics are called the lifetime risk of developing cancer.